Phase 1 Study of UniCAR02-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515827-12-00

Acronym

UC02-123-01

Enrollment

Registered

2024-08-02

Start date

2020-01-28

Completion date

2025-04-11

Last updated

2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia (AML)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026